AR033992A1 - Asociaciones sinergicas de dalfopristina/quinupristina con cefpiroma las composiciones farmaceuticas que los contienen y el kit de presentacion de dicha asociacion - Google Patents

Asociaciones sinergicas de dalfopristina/quinupristina con cefpiroma las composiciones farmaceuticas que los contienen y el kit de presentacion de dicha asociacion

Info

Publication number
AR033992A1
AR033992A1 ARP010103684A ARP010103684A AR033992A1 AR 033992 A1 AR033992 A1 AR 033992A1 AR P010103684 A ARP010103684 A AR P010103684A AR P010103684 A ARP010103684 A AR P010103684A AR 033992 A1 AR033992 A1 AR 033992A1
Authority
AR
Argentina
Prior art keywords
association
cefpiroma
pharmaceutical compositions
presentation
quinupristina
Prior art date
Application number
ARP010103684A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR033992A1 publication Critical patent/AR033992A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thyristors (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Se describe una asociación que tiene una acción sinérgica que comprende una combinación de quinupristina/dalfopristina con la cefpiroma. Además, se describen las composiciones farmacéuticas y los kits de presentación que contienen dicha asociación sinérgica. Esta asociación presenta una sinergía de acción tanto bacteriostática como bactericida y es útil, por lo tanto, para tratar infecciones muy dificiles de tratar y que requieren una acción bactericida rápida y eficaz.
ARP010103684A 2000-08-03 2001-08-01 Asociaciones sinergicas de dalfopristina/quinupristina con cefpiroma las composiciones farmaceuticas que los contienen y el kit de presentacion de dicha asociacion AR033992A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0010245A FR2812549B1 (fr) 2000-08-03 2000-08-03 Associations dalfopristine/quinupristine avec le cefpirome

Publications (1)

Publication Number Publication Date
AR033992A1 true AR033992A1 (es) 2004-01-21

Family

ID=8853264

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP010103684A AR033992A1 (es) 2000-08-03 2001-08-01 Asociaciones sinergicas de dalfopristina/quinupristina con cefpiroma las composiciones farmaceuticas que los contienen y el kit de presentacion de dicha asociacion

Country Status (29)

Country Link
US (2) US7005416B2 (es)
EP (1) EP1313500B1 (es)
JP (1) JP2004505926A (es)
KR (1) KR100808715B1 (es)
CN (1) CN1256982C (es)
AR (1) AR033992A1 (es)
AT (1) ATE279204T1 (es)
AU (2) AU8409501A (es)
BR (1) BR0112897A (es)
CA (1) CA2418023A1 (es)
CZ (1) CZ2003290A3 (es)
DE (1) DE60106463T2 (es)
DK (1) DK1313500T3 (es)
EA (1) EA007713B1 (es)
ES (1) ES2230358T3 (es)
FR (1) FR2812549B1 (es)
HK (1) HK1058305A1 (es)
HU (1) HU227455B1 (es)
IL (1) IL154237A0 (es)
MX (1) MXPA03000959A (es)
NO (1) NO20030483L (es)
NZ (1) NZ523982A (es)
PE (1) PE20020264A1 (es)
PL (1) PL204278B1 (es)
PT (1) PT1313500E (es)
SK (1) SK1202003A3 (es)
TN (1) TNSN01116A1 (es)
WO (1) WO2002011751A2 (es)
ZA (1) ZA200300903B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107420042B (zh) * 2017-09-25 2023-03-31 中国地质大学（武汉） 一种基于六自由度并联机构的海底钻机自动调平系统

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0867676A (ja) * 1994-03-30 1996-03-12 Eisai Kagaku Kk 保護アミノチアゾリル酢酸誘導体
US5464616A (en) * 1994-08-04 1995-11-07 Synphar Laboratories, Ind. 6β-substituted penicillanic acids as beta-lactamase inhibitors
US5686441A (en) * 1995-08-04 1997-11-11 Syphar Laboratories, Inc. Penam sulfones as β-lactamase inhibitors
FR2755857B1 (fr) * 1996-11-19 1998-12-24 Rhone Poulenc Rorer Sa Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
US6187746B1 (en) * 1997-12-16 2001-02-13 Rhone-Poulenc Rorer S.A. Pharmaceutical compositions based on dalfopristine and on quinupristine, and preparation thereof
US6465428B1 (en) * 1999-08-27 2002-10-15 Aventis Pharma S.A. Pharmaceutical combinations based on dalfopristine and quinupristine, and on cefepime

Also Published As

Publication number Publication date
HU227455B1 (en) 2011-06-28
US7005416B2 (en) 2006-02-28
FR2812549A1 (fr) 2002-02-08
WO2002011751A2 (fr) 2002-02-14
DE60106463D1 (de) 2004-11-18
CA2418023A1 (fr) 2002-02-14
KR100808715B1 (ko) 2008-02-29
CZ2003290A3 (cs) 2003-05-14
CN1256982C (zh) 2006-05-24
EP1313500A2 (fr) 2003-05-28
WO2002011751A3 (fr) 2002-06-13
TNSN01116A1 (fr) 2005-11-10
NO20030483D0 (no) 2003-01-30
HUP0300682A3 (en) 2004-09-28
BR0112897A (pt) 2003-06-10
CN1449290A (zh) 2003-10-15
HUP0300682A2 (hu) 2003-08-28
SK1202003A3 (en) 2003-07-01
EA200300214A1 (ru) 2003-06-26
JP2004505926A (ja) 2004-02-26
DE60106463T2 (de) 2005-10-13
HK1058305A1 (en) 2004-05-14
EA007713B1 (ru) 2006-12-29
ZA200300903B (en) 2003-11-10
DK1313500T3 (da) 2005-02-14
FR2812549B1 (fr) 2003-03-21
PT1313500E (pt) 2005-02-28
ES2230358T3 (es) 2005-05-01
US20020037890A1 (en) 2002-03-28
PE20020264A1 (es) 2002-05-20
EP1313500B1 (fr) 2004-10-13
NO20030483L (no) 2003-01-30
ATE279204T1 (de) 2004-10-15
AU2001284095B2 (en) 2007-04-05
AU8409501A (en) 2002-02-18
IL154237A0 (en) 2003-07-31
PL365075A1 (en) 2004-12-27
PL204278B1 (pl) 2009-12-31
KR20030022351A (ko) 2003-03-15
MXPA03000959A (es) 2003-06-09
US20060122103A1 (en) 2006-06-08
NZ523982A (en) 2004-10-29

Similar Documents

Publication Publication Date Title
ES2146300T3 (es) Utilizacion de composiciones antihelminticas para el tratamiento de infecciones causadas por anoplocephala perfoliata en equidos.
AR028296A1 (es) Metodos sinergisticos y composiciones para el tratamiento del cancer
PA8523201A1 (es) Nueva composicion farmaceutica
GT200600520A (es) Agentes antibacterianos
AR031478A1 (es) Composiciones antimicrobianas que contienen compuestos de amonio cuaternario, silanos y otros desinfectantes con furanonas
AR024874A1 (es) Composiciones bactericidas
CR7716A (es) Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor
AR047070A1 (es) Derivados de difenilazetidona
DE602004016831D1 (de) Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos
BRPI0212298B8 (pt) composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico
ECSP066685A (es) Composición que comprende un extracto acuoso de hojas de vid roja y un agente que mejora la circulación sanguínea para el tratamiento de insuficiencias venosas crónicas
ES2174921T3 (es) Inhibidores de la proteasa del vih.
AR008797A1 (es) Composicion.
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
AR030957A1 (es) Composiciones de analgesico y glucosamina
BR9712141A (pt) Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas.
DK1414467T3 (da) Topisk behandling af mastalgi
AR052048A1 (es) Composiciones farmaceuticas para el tratamiento de la celulitis
UY26895A1 (es) Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2
DE602004014787D1 (de) Anti-tumorale formulierungen mit defibrotid allein oder in kombination mit anderen antitumoralen mitteln
AR033992A1 (es) Asociaciones sinergicas de dalfopristina/quinupristina con cefpiroma las composiciones farmaceuticas que los contienen y el kit de presentacion de dicha asociacion
DE602005021095D1 (de) Antimikrobielle zusammensetzungen und ihre verwendungen
GT199600072A (es) Formas zwitterionicas de trovafloxacina.
AR034606A1 (es) Composiciones cosmeticas

Legal Events

Date Code Title Description
FB Suspension of granting procedure